Published in Carcinogenesis on June 01, 1989
Environmental carcinogenic polycyclic aromatic hydrocarbons: photochemistry and phototoxicity. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2002) 1.80
Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J (2009) 1.31
Preneoplastic and neoplastic lesions in the lung, liver and urinary tract of mice exposed to environmental cigarette smoke and UV light since birth. Int J Cancer (2008) 0.88
Genotoxicity of chromium compounds. A review. Mutat Res (1990) 1.68
Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis (2001) 1.52
Oxidative stress and glaucoma: injury in the anterior segment of the eye. Prog Brain Res (2008) 1.15
Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. Cancer Res (2001) 1.13
The role of the thiol N-acetylcysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers (2000) 1.11
Chemopreventive properties and mechanisms of N-Acetylcysteine. The experimental background. J Cell Biochem Suppl (1995) 1.11
Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Res (1996) 1.11
Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats. Carcinogenesis (2001) 1.10
Gene-environment interactions in ocular diseases. Mutat Res (2008) 1.09
N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest (1999) 1.06
Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis (1997) 1.05
Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J (1997) 1.01
Molecular epidemiology of atherosclerosis. FASEB J (1997) 1.00
DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. Cancer Res (1981) 0.98
Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int J Cancer (1995) 0.97
Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat Res (1988) 0.97
Aqueous humor oxidative stress proteomic levels in primary open angle glaucoma. Exp Eye Res (2012) 0.95
Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents. Cancer Res (1999) 0.92
Physical activity and cancer prevention: a review of current evidence and biological mechanisms. J Prev Med Hyg (2011) 0.92
DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine. Mutat Res (1996) 0.92
Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models. Int J Cancer (1996) 0.92
Mutagenicity testing with TA97 and TA102 of 30 DNA-damaging compounds, negative with other Salmonella strains. Mutat Res (1985) 0.91
Multiple genotoxicity biomarkers in fish exposed in situ to polluted river water. Mutat Res (1993) 0.91
Formation and persistence of nucleotide alterations in rats exposed whole-body to environmental cigarette smoke. Carcinogenesis (1999) 0.90
Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus. Carcinogenesis (1989) 0.88
Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res (2001) 0.88
Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res (1999) 0.88
Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test. Mutat Res (1984) 0.87
Ozone air pollution and daily mortality in Genoa, Italy between 1993 and 1996. Public Health (2005) 0.86
In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. Carcinogenesis (1985) 0.85
Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement. Cancer Epidemiol Biomarkers Prev (1995) 0.85
Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients. Mutat Res (1991) 0.84
Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke. J Clin Invest (1986) 0.84
Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer. Am J Med (1991) 0.84
Genotoxic, carcinogenic, and teratogenic hazards in the marine environment, with special reference to the Mediterranean Sea. Mutat Res (1991) 0.84
Metabolic reduction of chromium, as related to its carcinogenic properties. Biol Trace Elem Res (1990) 0.84
Protection by N-acetylcysteine of the histopathological and cytogenetical damage produced by exposure of rats to cigarette smoke. Cancer Lett (1992) 0.84
Less than additive interaction between cigarette smoke and chromium(VI) in inducing clastogenic damage in rodents. Carcinogenesis (2000) 0.83
Metabolic alterations produced by cigarette smoke in rat lung and liver, and their modulation by oral N-acetylcysteine. Mutagenesis (1992) 0.83
Pulmonary metabolism of mutagens and its relationship with lung cancer and smoking habits. Cancer Res (1987) 0.83
Antiapoptotic and antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin. Anticancer Res (2000) 0.83
Dopamine D2 receptor stimulation decreases the inositol trisphosphate level of rat striatal slices. Eur J Pharmacol (1987) 0.83
Pilot studies evaluating the lung tumor yield in cigarette smoke-exposed mice. Int J Oncol (2001) 0.83
Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo. J Pharmacol Exp Ther (1993) 0.83
Assessment of antimutagenicity and anticarcinogenicity. Mutat Res (1992) 0.83
Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat Res (2001) 0.82
Prevention by N-acetylcysteine of benzo[a]pyrene clastogenicity and DNA adducts in rats. Mutat Res (1991) 0.82
In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens. Carcinogenesis (1984) 0.82
Modulation of the mutagenic response in prokaryotes. Mutat Res (1992) 0.82
Specificity and inducibility of the metabolic reduction of chromium(VI) mutagenicity by subcellular fractions of rat tissues. Cancer Res (1985) 0.81
Degenerative periodontal-diseases and oral osteonecrosis: the role of gene-environment interactions. Mutat Res (2008) 0.81
Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region. Eur J Cancer (1996) 0.81
Interactions between N-acetylcysteine and ascorbic acid in modulating mutagenesis and carcinogenesis. Int J Cancer (2000) 0.81
Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention. IARC Sci Publ (1996) 0.81
Formation of DNA adducts in the aorta of smoke-exposed rats, and modulation by chemopreventive agents. Mutat Res (2001) 0.80
Inhibition of the de-myelinating properties of Aicardi-Goutières syndrome lymphocytes by cathepsin D silencing. Biochem Biophys Res Commun (2012) 0.80
Oltipraz chemoprevention trial in Qidong, People's Republic of China: results of urine genotoxicity assays as related to smoking habits. Cancer Epidemiol Biomarkers Prev (2001) 0.80
Inhibition of urethan-induced lung tumors in mice by dietary N-acetylcysteine. Cancer Lett (1986) 0.80
Metabolic activation and deactivation of mutagens by preparations of human lung parenchyma and bronchial tree. Mutat Res (1984) 0.80
Mutagenicity of polycyclic aromatic hydrocarbon fractions extracted from urban air particulates. Mutat Res (1989) 0.80
Metabolism of mutagens and carcinogens in woodchuck liver and its relationship with hepatitis virus infection. Cancer Res (1987) 0.80
Inhibition of the 'spontaneous' mutagenicity in Salmonella typhimurium TA102 and TA104. Mutat Res (1994) 0.80
Carcinogen metabolism studies in human bronchial and lung parenchymal tissues. Am Rev Respir Dis (1989) 0.80
Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B. Environ Health Perspect (1994) 0.80